Product News
Cherwell has announced additions to the ImpactAir range of microbial air monitors
The extended range promises a flexible solution to best fit customer needs and applications while ensuring GMP Annex 1 compliance
News & Articles
25
Product News
Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI
Editorial Article
Meet the analytical balance punching well above its weight
Christian Weidner reveals the balance set to become a laboratory must-have, promising precision, repeatability, and reliability at an affordable price
Industry News
BellBrook Labs receive NIH grant to treat lupus and related autoimmune diseases
The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway
Product News
Bio-Rad has launched SARS-CoV-2 Variant RT-PCR Assays
The assays will help public health researchers track SARS-CoV-2 variants more rapidly and cost-effectively
Editorial Article
Advance your drug discovery and development with improved drug screening, imaging, and characterization
Explore exclusive interviews and the latest resources to support your drug discovery workflows, from chemical imaging and fragment screening to assay development and gene therapy
Editorial Article
Targeting protein-protein interactions (PPIs): Identifying PPI inhibitors for novel therapeutics
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
Editorial Article
Virtual Cancer and Immunology Research Summit 2021: Full meeting agenda
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
Industry News
New data for Roche’s OCREVUS reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis
OCREVUS significantly slowed loss of brain tissue within T2 MRI lesions in primary progressive multiple sclerosis (PPMS) in post-hoc analysis of Phase III ORATORIO study